Agree, Director buying always a good sign. However, there was recent buying in early March with one Director buying shares to the value of around $2 million. The average price of these x2 tranches was 31.55 cents, which is not too far below the current price. I took this to be a good sign and I also bought back-in.
I am not a trader and am not concerned about short term price volatility. Instead, I am a conviction/value investor looking to buy-in on SP dips for the longer term when there local/national/global tailwinds evident. I think a global health pandemic counts in relation to a tailwind for a drug company!
Agree, Director buying always a good sign. However, there was...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |